Rating History for Eagle Pharmaceuticals (EGRX) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/9/2023 | David Amsellem | Downgrade | Underweight (Neutral) |
17.00 (N/A) |
22.88 (2.14) |
-90.65% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
